In this video Joel Hardy, CEO of Cymra Life Sciences explains how the genetic engineering of cannabis will help create medicine specifically for chronic pain patients. He also tells us how the field of cannabis genetics will help lower the cost of cannabis to patients over time.
———-
00:17 – The need more solutions for chronic pain treatment.
01:14 – What makes chronic pain so important to Cymra?
02:32 – How Cymra is addressing chronic pain through cannabis genetics
03:34 – Cannabis genetics’ impact consumers in the long run
05:12 – Clinical trial on the new plant breeds (for chronic pain)
06:08 – How to participate in the trial
———-
To read the article, please visit:
https://honahlee.com.au/articles/cannabis-genetic-engineering-chronic-pain/
To ask an expert a question visit:
https://honahlee.com.au/ask/
Or follow honahlee on social media:
– https://www.facebook.com/honahleeau
– https://www.instagram.com/honahleeau/
– https://www.linkedin.com/company/honahleeau
– https://www.pinterest.com.au/honahleeau/
Disclaimer: Currently, in Australia, cannabis is only legal with a prescription. The team at honahlee are not doctors and are not providing medical advice. Neither Joel Hardy nor the honahlee team are recommending the use of marijuana (cannabis) for medical or adult use purposes. Cannabis does not work for everyone and may have negative side effects. In Australia, medical marijuana (cannabis) is regulated by the TGA. If you think cannabis is right for you, please consult with your doctor or specialist.
source
